However, due to reduced STAT3 phosphorylation in HIES patients, this STAT3 and NF-κB p50 interaction to the RANTES promoter would be compromised that it will lead to a reduced expression of downstream signaling molecules. The gene discussed is CCL5; the disease is hyper-IgE syndrome.